Modification of tamoxifen response: what have we learned?
Lash
Timothy L
TL
Ahern
Thomas P
TP
Cronin-Fenton
Deirdre
D
Garne
Jens Peter
JP
Hamilton-Dutoit
Stephen
S
Kvistgaard
Marianne Ewertz
ME
Rosenberg
Carol L
CL
Silliman
Rebecca A
RA
Sørensen
Henrik Toft
HT
D000483:Alleles; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000235:genetics; D017024:Chemotherapy, Adjuvant; D019389:Cytochrome P-450 CYP2D6 / Q000235:genetics*; D019008:Drug Resistance, Neoplasm / Q000235:genetics*; D005260:Female; D006801:Humans; D010597:Pharmacogenetics; D011960:Receptors, Estrogen / Q000378:metabolism; D020845:Selective Estrogen Receptor Modulators / Q000378:metabolism / Q000627:therapeutic use*; D013629:Tamoxifen / Q000378:metabolism / Q000627:therapeutic use*
D011960:Receptors, Estrogen; D020845:Selective Estrogen Receptor Modulators; D013629:Tamoxifen; D019389:Cytochrome P-450 CYP2D6